214 related articles for article (PubMed ID: 23308056)
1. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.
Mohammed A; Janakiram NB; Brewer M; Duff A; Lightfoot S; Brush RS; Anderson RE; Rao CV
Neoplasia; 2012 Dec; 14(12):1249-59. PubMed ID: 23308056
[TBL] [Abstract][Full Text] [Related]
2. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
He P; Yang JW; Yang VW; Bialkowska AB
Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.
Rao CV; Mohammed A; Janakiram NB; Li Q; Ritchie RL; Lightfoot S; Vibhudutta A; Steele VE
Neoplasia; 2012 Sep; 14(9):778-87. PubMed ID: 23019409
[TBL] [Abstract][Full Text] [Related]
4. The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.
Mohammed A; Janakiram NB; Li Q; Madka V; Ely M; Lightfoot S; Crawford H; Steele VE; Rao CV
Cancer Prev Res (Phila); 2010 Nov; 3(11):1417-26. PubMed ID: 21084261
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.
Mohammed A; Qian L; Janakiram NB; Lightfoot S; Steele VE; Rao CV
Int J Cancer; 2012 Oct; 131(8):1951-62. PubMed ID: 22287227
[TBL] [Abstract][Full Text] [Related]
6. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.
DiNorcia J; Lee MK; Moroziewicz DN; Winner M; Suman P; Bao F; Remotti HE; Zou YS; Yan SF; Qiu W; Su GH; Schmidt AM; Allendorf JD
J Gastrointest Surg; 2012 Jan; 16(1):104-12; discussion 112. PubMed ID: 22052106
[TBL] [Abstract][Full Text] [Related]
7. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice.
Philip B; Roland CL; Daniluk J; Liu Y; Chatterjee D; Gomez SB; Ji B; Huang H; Wang H; Fleming JB; Logsdon CD; Cruz-Monserrate Z
Gastroenterology; 2013 Dec; 145(6):1449-58. PubMed ID: 23958541
[TBL] [Abstract][Full Text] [Related]
8. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.
Bai H; Li H; Zhang W; Matkowskyj KA; Liao J; Srivastava SK; Yang GY
Carcinogenesis; 2011 Nov; 32(11):1689-96. PubMed ID: 21859833
[TBL] [Abstract][Full Text] [Related]
11. Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention.
Mohammed A; Janakiram NB; Suen C; Stratton N; Lightfoot S; Singh A; Pathuri G; Ritchie R; Madka V; Rao CV
Mol Carcinog; 2019 Oct; 58(10):1908-1918. PubMed ID: 31313401
[TBL] [Abstract][Full Text] [Related]
12. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.
Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766
[No Abstract] [Full Text] [Related]
13. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
14. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of
Saeki K; Qiu W; Friedman RA; Pan S; Lu J; Ichimiya S; Chio IIC; Shawber CJ; Kitajewski J; Hu J; Su GH
Cancer Res Commun; 2022 Dec; 2(12):1601-1616. PubMed ID: 36970723
[TBL] [Abstract][Full Text] [Related]
16. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer.
Lanza-Jacoby S; Yan G; Radice G; LePhong C; Baliff J; Hess R
Exp Biol Med (Maywood); 2013 Jul; 238(7):787-97. PubMed ID: 23828595
[TBL] [Abstract][Full Text] [Related]
17. Identification and manipulation of biliary metaplasia in pancreatic tumors.
Delgiorno KE; Hall JC; Takeuchi KK; Pan FC; Halbrook CJ; Washington MK; Olive KP; Spence JR; Sipos B; Wright CV; Wells JM; Crawford HC
Gastroenterology; 2014 Jan; 146(1):233-44.e5. PubMed ID: 23999170
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
Fendrich V; Sparn M; Lauth M; Knoop R; Plassmeier L; Bartsch DK; Waldmann J
Pancreatology; 2013; 13(5):502-7. PubMed ID: 24075515
[TBL] [Abstract][Full Text] [Related]
19. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
Keenan BP; Saenger Y; Kafrouni MI; Leubner A; Lauer P; Maitra A; Rucki AA; Gunderson AJ; Coussens LM; Brockstedt DG; Dubensky TW; Hassan R; Armstrong TD; Jaffee EM
Gastroenterology; 2014 Jun; 146(7):1784-94.e6. PubMed ID: 24607504
[TBL] [Abstract][Full Text] [Related]
20. Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer.
Mohammed A; Janakiram NB; Madka V; Pathuri G; Li Q; Ritchie R; Biddick L; Kutche H; Zhang Y; Singh A; Gali H; Lightfoot S; Steele VE; Suen CS; Rao CV
Oncotarget; 2017 Nov; 8(58):97822-97834. PubMed ID: 29228654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
